Eastman Chemical Company (EMN) Q3 2025 earnings summary

Executive summary

• Management expects meaningful earnings growth in 2026, driven by cost reductions, asset utilization tailwinds, and innovation, particularly in circular recycling and specialty products.

• Q3 2025 sales revenue declined 11% year-over-year, mainly due to lower volumes and persistent end-market weakness, but strong cash flow was maintained through inventory reduction and cost controls.

• Returned $146 million to shareholders via dividends and share repurchases in Q3 2025.

• Continued ramp-up in the circular economy platform, with methanolysis production exceeding 2.5x 2024 levels and over 100 specialty customers paying premiums.

• Cost structure reduction on track for over $75 million net of inflation in 2025 and an additional $100 million in 2026.

Financial highlights

• Q3 2025 revenue was $2.20 billion, down 11% year-over-year; adjusted EBIT was $210 million, down from $366 million in Q3 2024.

• Adjusted EBIT margin declined to 9.5% from 14.9% year-over-year.

• Diluted EPS was $0.40, down from $1.53; adjusted EPS was $1.14, down from $2.26.

• Gross profit margin decreased to 19.7% from 24.6% year-over-year.

• Net debt increased to $4.59 billion at September 30, 2025, from $4.18 billion at year-end 2024.

Outlook and guidance

• Full-year 2025 adjusted EPS is projected between $5.40 and $5.65, with operating cash flow approaching $1 billion.

• Management expects a recovery in stable markets and a significant step up in rPET and specialty revenue in 2026.

• On track for $75 million cost reduction in 2025 and $100 million in 2026, net of inflation.

• Expect greater than normal seasonal volume decline in Q4 2025 due to continued macroeconomic weakness.

• 2025 capital expenditures projected at approximately $550 million, with lower capex in 2026.